Wakilii

Friecca Pharmacy Ltd v National Drug Authority & 2 Others (Civil Suit 731 of 2017)

High Court · [2018] UGCOMMC 85 · 2018 Application Dismissed AI-generated summary ↓ Download Pin to watchlist Add to matter
Jurisdiction
Uganda
Case Type
Commercial suit for permanent injunction based on alleged violation of 200-metre pharmacy exclusivity rule; preliminary objection raised by defendants challenging competence and prematurity of suit
Decision
Suit dismissed as premature without prejudice; may be reinstated if plaintiff's rights are subsequently violated by NDA's decision on relocation application

Observed later treatment

Cited — treatment unverified cited in 1 (treatment unverified) Sequitur — Uganda’s citator · Derived from citing cases in the Wakilii corpus — not an assertion that this case is good law.

Citator coverage is limited to judgments in the Wakilii corpus and source-matched treatment records. Absence of a signal is not an assertion that the case remains good law.

No adverse treatment recorded Cited 1 time with no adverse treatment recorded; not yet tested on the merits. Derived from citing cases in the Wakilii corpus — a deterministic signal, not legal advice.

AI-generated summary. This summary was generated by AI from the full text of the judgment. It may contain errors or omissions—always read the source judgment before relying on it.

Holding

The court held that the plaintiff's suit was premature and disclosed no cause of action because no right had been violated — the 1st Defendant had not yet granted relocation approval to the 2nd and 3rd Defendants. The plaintiff's claim was speculative, anticipating a decision that might harm its business. The court could not restrain a statutory body from exercising its mandate absent illegality or an actual decision. The suit was dismissed without prejudice, with leave to reinstate if the plaintiff's rights were later violated by NDA's decision.

Outcome

Suit dismissed as premature without prejudice; may be reinstated if plaintiff's rights are subsequently violated by NDA's decision on relocation application

Facts

The plaintiff, Friecca Pharmacy Ltd, operated a retail pharmacy at Plot 210 Kibuga in Wandegeya since 1996. The 2nd Defendant (Guardian Health Ltd) and 3rd Defendant (Natif Anthony, a shareholder and director of the 2nd Defendant) applied to the 1st Defendant (National Drug Authority) for approval to relocate a pharmacy to premises within 200 metres of the plaintiff's pharmacy. Before NDA decided the relocation application, the plaintiff filed suit seeking a permanent injunction restraining NDA from granting the licence, alleging violation of a 200-metre exclusivity rule under NDA guidelines and unfair competition. The defendants commenced renovation works on the new premises before obtaining relocation approval. The plaintiff filed a complaint with NDA on 11 September 2017, which had not been resolved by the time of suit.

Issues

  1. Whether the Plaintiff's suit discloses a cause of action
  2. Whether the Plaintiff's suit is premature
  3. Whether the Licensing guidelines 2017 issued by the first Defendant on 01.12.2016 are still in force or enforceable
  4. Whether the Professional Licencing Guidelines (Amended) 2017 are enforceable

Orders

  • Case dismissed as premature.
  • Miscellaneous Application 1108 of 2017 dismissed accordingly.
  • Each party to bear its own costs.
  • Leave granted to reinstate the case if the Plaintiff's rights are violated by the 1st Defendant's decision on the relocation application.

Rules and key headnotes

Administrative Law — Cause of Action — Prematurity — Anticipatory Relief
A suit seeking to restrain a statutory body from exercising its mandate is premature and discloses no cause of action where no decision has been made and no right has been violated; a plaintiff cannot maintain an action based on anticipated harm from a decision not yet taken.
Administrative Law — Cause of Action — Essential Elements
To sustain a cause of action, three ingredients must be satisfied: the plaintiff enjoyed a right, that right was violated, and the defendant is liable; these requirements must be established on a prima facie basis from the plaint and its annexures alone.
Commercial Law — Competition — Unfair Competition — Protection from Competition
The law does not protect a business from legitimate competition; a claim of unfair competition must demonstrate prohibited practices such as price fixing, collusive tendering, market allocation, or refusals to supply, not merely the existence of competing businesses in the same neighbourhood.
Judicial Review — Proper Procedure — Commercial Suit versus Judicial Review
Where a plaintiff seeks to challenge the exercise of statutory powers by a regulatory authority, the proper procedure is judicial review, not a commercial suit; courts can only intervene to correct illegality, procedural impropriety, or abuse of power after a decision has been made.

Cases cited (4)

  • Auto Garage v Motokov (1971) EA 314
  • Serugo Ismail v KCCA (Constitutional Appeal No. 2 of 1998)
  • Bakwanye Trading Co Ltd v Uganda Revenue Authority (Civil Suit No. 602 of 2006)
  • Jeraj Shariff & Co v Chotai Fancy Stores (1960) EA 374

Cases citing this judgment (1)

How later Ugandan judgments in the Wakilii corpus have cited this case. Treatment labels come from Sequitur — Uganda’s citator — each backed by a verbatim span from the citing judgment, and are not an assertion that this case is, or is not, good law.

Full judgment

↓ Download PDF

The original judgment as reported. Read the original PDF before relying on any passage.

Friecca Pharmacy Ltd v National Drug Authority & 2 Others (Civil Suit 731 of 2017) [2018] UGCommC 85 (30 July 2018)
Source: this page presents Wakilii’s issue analysis and metadata for a publicly reported Ugandan judgment. Any AI-generated summary is marked as such. Judgment text is sourced from the Uganda Legal Information Institute (ulii.org). Wakilii is not affiliated with ULII.